Contact this trialFirst, we need to learn more about you.
Checkpoint Inhibitor
Subcutaneous vs Intravenous Nivolumab for Kidney Cancer
Recruiting2 awardsPhase 3
West Reading, Pennsylvania
This trial will compare the effects of two ways of administering the drug nivolumab in patients who have a certain type of kidney cancer that has come back or spread.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service